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The process of pain perception begins in the periphery by activation of nociceptors.
From here nociceptive signals are conveyed via the dorsal horn of the spinal cord to
multiple brain regions, where pain is perceived. Despite great progress in pain research in
recent years, many questions remain regarding nociceptive circuitry and behavior, in both
acute nociception and chronic pain states. Techniques that allow for selective activation
of neuronal subpopulations in vivo can provide a better understanding of these complex
pathways. Here we review the studies to date that have employed novel optogenetic tools
to improve our understanding of the pain pathway at the peripheral, spinal and supraspinal
levels.
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CIRCUITS AND CELL TYPES INVOLVED IN PAIN
Chronic pain represents a significant clinical problem affecting
up to 20% of the general population (Breivik et al., 2006; Reid
et al., 2011) and is a symptom of a variety of different underly-
ing pathologies including arthritis, nerve injury, depression and
cancer. An understanding of nociceptive mechanisms and the
neurobiology of pain perception are necessary to better treat
chronic pain conditions. Here we provide a brief overview of the
circuitry and cell types involved, and review studies to date that
have used optogenetic tools to manipulate these pathways.
Unlike some neurobiological disorders which can be attributed
to specific brain regions, pain incorporates multiple components
of the nervous system, at the peripheral, spinal, and supraspinal
levels. The first components of the pain pathway are the peripheral
nociceptors. These are a heterogeneous population, and can be
classified in a variety of ways including myelination properties,
expression of transducer molecules, peptidergic content and volt-
age gated sodium channel expression (Gold and Gebhart, 2010).
Transgenic mice have been invaluable in demonstrating that noci-
ceptor heterogeneity is of functional significance, with different
nociceptors contributing to distinct nociceptive modalities such
as heat and mechanical pain (Abrahamsen et al., 2008; Cavanaugh
et al., 2009). Nociceptor subtypes also contribute in distinct ways
to different forms of chronic pain such as inflammatory and
neuropathic states (Cavanaugh et al., 2009; Seal et al., 2009;
Minett et al., 2012). Activation of specific nociceptor subtypes in
the intact system will be helpful in confirming modality specificity
in pain, and determining appropriate peripheral targets for novel
therapeutic strategies.
The dorsal horn of the spinal cord, where the majority of noci-
ceptors terminate, provides the next level of complexity in pain
processing. An exception to this are the trigeminal nociceptors,
which innervate the head and facial areas and terminate in the
medullary dorsal horn (Ren and Dubner, 1999). Interneurons are
the most numerous population in the dorsal horn (Todd, 2010)
and the balance between excitation and inhibition within the
dorsal horn may be disrupted in chronic pain states. For instance,
it is known that decreased GABAergic and glycinergic inhibition
contribute to neuropathic pain hypersensitivity (Moore et al.,
2002; Lu et al., 2013). In addition subtypes of glutamatergic
interneurons may play distinct roles in acute, inflammatory and
neuropathic pain states (Wang et al., 2013). To date our under-
standing of interneuron circuitry in the dorsal horn is based
largely on electrophysiological and pharmacological approaches.
Given the pivotal role of interneurons in the gate control theory
of pain (Melzack, 1999), regional and cell type specific activation
using optogenetics will be a powerful way to investigate this
important circuitry.
The principal direct targets of dorsal horn projection neurons
are the parabrachial area and thalamus (Gauriau and Bernard,
2002, 2004). From here a range of areas are activated including
the somatosensory cortex, anterior cingulate, prefrontal cortex
(PFC), and amygdala (Apkarian et al., 2005; Tracey and Mantyh,
2007; Baliki et al., 2013). It is important to note that chronic pain
states are frequently accompanied by psychological symptoms
such as anxiety and depression (Bushnell et al., 2013) and under-
standing the role of brain areas in both the sensory and affective
components of pain is important for the development of novel
treatment approaches. Another important aspect of pain circuitry
to be considered is the top-down pain modulatory system, which
allows higher brain structures to signal to the dorsal horn to
regulate nociceptive processing. This may be either inhibitory or
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FIGURE 1 | Overview of the pain pathway, and list of optogenetic
studies to date that have targeted each level. The full arrows
indicate the ascending pain pathway, while the descending pathway is
represented by dashed arrows. Different categories of nociceptor,
including unmyelinated C-fibers and myelinated Aδ-fibers are shown.
For clarity, only a selection of brain regions activated during
nociception are shown: prefrontal cortex (PFC), anterior cingulate
cortex (ACC), central nucleus of the amygdala (CeA), parabrachial area
(PB), periaqueductal gray (PAG) and rostral ventromedial medulla
(RVM).
facilitatory in nature, arises from a variety of brain structures and
is relayed to the dorsal horn via the rostral ventromedial medulla
(RVM; Ossipov et al., 2010). Optogenetic approaches will allow
further investigation of these ascending and descending circuits
in animal pain behavior (Figure 1).
OPTOGENETIC STIMULATION OF NOCICEPTORS IN C. ELEGANS
C. elegans was the first multicellular organism to be investigated
using optogenetic methods (Nagel et al., 2005), and is one of
the most useful simple organisms in the study of genetics and
molecular biology. Many advances in neuroscience and behavior
have also been made using this system. C. elegans is particu-
larly useful in the study of nociception as it exhibits a clear
and reproducible withdrawal behavior, involving a reversal and
change in direction away from the noxious stimulus (Wittenburg
and Baumeister, 1999; Tobin and Bargmann, 2004). Recently,
optogenetic activation of C. elegans nociceptors has been used to
characterize molecules associated with nociception (Husson et al.,
2012). Channelrhodopsin 2 was expressed under the control of
the F49H12.4 promoter, predominantly found within PVD noci-
ceptive neurons. Stimulation of the worm with blue light therefore
allowed activation of the nociceptive network, without activating
other non-noxious mechanical sensing neurons. Interestingly,
activation of these nociceptors is less susceptible to habituation
than other sensory responses in C. elegans. The authors used this
technique to screen for genes involved in mediating the nocicep-
tive response in the PVD neuron, investigating the contribution
of RNA interference for various target genes to the optogeneti-
cally induced nociceptive behavior. This led to the identification
of a number of genes involved in nociceptive transmission in
the organism, including voltage gated calcium channel subunits
and melastatin-related transient receptor (TRPM) channels. This
study highlights the potential of using optogenetically triggered
behavior as a method to screen for novel nociceptive mediators,
or even analgesics.
OPTOGENETIC STIMULATION OF SPECIFIC NOCICEPTOR POPULATIONS
IN MICE
Optogenetic stimulation of a subset of peripheral nociceptor has
also been used as a tool to characterize the spinal cord cir-
cuitry associated with that nociceptor subtype (Wang and Zylka,
2009). Mas-related G protein coupled receptor D (Mrgprd) is
a marker for a subset of non-peptidergic nociceptors in the rat
and mouse. These neurons appear to be involved in mediating
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mechanical nociception, but not noxious thermal or cold stimuli
(Cavanaugh et al., 2009). Although anatomically it is known that
Mrgprd-positive fibers terminate largely in lamina II of the dorsal
horn, the precise connectivity of this nociceptor subpopulation
was not known. In contrast to the variety of molecular mark-
ers available to characterize nociceptor populations, relatively
few markers are available to characterize neuronal populations
in the dorsal horn. To characterize the dorsal horn neurons
innervated by Mrgprd expressing primary afferents, Wang and
colleagues used a combined optogenetic and electrophysiolog-
ical approach (Wang and Zylka, 2009). Knock-in mice were
generated to express channlerhodopsin-2 at the Mrgprd locus,
allowing this nociceptor population to be selectively activated by
blue light. Patch clamp recordings from lamina II dorsal horn
neurons were made using a slice preparation and stimulation
of Mrgprd expressing terminals by brief high frequency blue
light application. This was sufficient to induce excitatory post
synaptic potentials in 50% of the lamina II neurons recorded.
The non-responsive lamina II neurons are therefore likely to be
innervated by other afferents, such as peptidergic nociceptors,
supporting the view that pain processing is modality specific at
both the peripheral and spinal levels. Interestingly this prepara-
tion illustrates that stimulation of channelrhodopsin-2 on axon
terminals is sufficient to evoke post synaptic activity, as the
dorsal root ganglions (DRGs) were not attached. This study high-
lights the potential of optogenetics in understanding the complex
pain related circuitry within the dorsal horn. Unlike traditional
electrophysiological studies which use electrical stimulation of
afferents or application of a noxious stimulus, the optogenetic
approach allows precise stimulation a defined nociceptor pop-
ulation. This is of great interest for the understanding connec-
tivity between peripheral nociceptors and neurons in the spinal
cord.
Recently, an alternative approach has been used to explore the
use of optogenetics in pain studies. Nav1.8 encodes a voltage gated
sodium channel expressed in nociceptors, and Nav1.8 express-
ing primary afferent neurons have been previously shown to
contribute to inflammatory and neuropathic pain (Abrahamsen
et al., 2008). Many studies have used the Nav1.8-Cre mice as
a background to study the role of particular genes in noci-
ception and pain-like behaviors (Stirling et al., 2005). This
mouse model has now been used to express channelrhodopsin-
2 specifically in nociceptors. Stimulation of the hindpaw with
blue light was sufficient to induce a number of characteristic
nocifensive behaviors, including paw withdrawal, licking, jump-
ing and vocalizations, in freely moving mice. Therefore this
study provides the first evidence that optical stimulation of
peripheral nociceptors can trigger nocifensive behaviors in the
awake and freely moving animal (Daou et al., 2013). Further-
more, c-Fos labeling of the dorsal horn following this pattern
of optical activation indicated activation of both lamina I and
lamina II dorsal horn neurons, suggesting that both peptider-
gic nociceptors and non-peptidergic nociceptors are activated.
Interestingly, the authors found that optogenetic stimulation
of Nav1.8 nociceptors is also capable of driving long term
hypersensitivity to mechanical and thermal stimuli, mimick-
ing aspects of chronic pain models in mice. As pain has an
important affective component, the authors also demonstrated
that blue light could drive conditioned place aversion in these
animals.
In contrast to the approach taken by Zlyka et al. in which
channelrhodopsin was inserted into the locus of a low abundance
marker of a subset of nociceptors, the Nav1.8-Cre approach
may be more useful for behavioral studies, and investigations of
spinal and supraspinal activation, given that a greater number of
nociceptors will be activated in this way.
OPTOGENETIC STUDIES OF BRAIN REGIONS INVOLVED IN PAIN
To date few studies have used optogenetic techniques to address
the role of specific brain regions in pain behavior in rodents.
One example has incorporated optogenetic stimulation to inves-
tigate the role of the central nucleus of the amygdala (CeA) in
a mouse model of visceral pain (Crock et al., 2012). Visceral
pain is a common complaint, and can be modeled in rodents
by bladder or colorectal distension. In the study by Crock and
colleagues, bladder distention was carried out, and the visceromo-
tor response (VMR, elecromyographic response of the abdominal
muscle) used as an index of visceral sensitivity. The amygdala is
important in the affective dimensions of the pain response, and
previous work had shown that the c-fos expression is increased
in the CeA following noxious visceral stimulation (Han and
Neugebauer, 2004). To explore this further, the right CeA was
injected with herpes simplex virus (HSV) viral vector expressing
channelrhodopsin-2. Optogenetic stimulation was carried out
for 30 min before, during or after bladder distension. Optical
stimulation before distension increased VMR sensitivity. This
hypersensitivity was maintained for up to 15 min following the
termination of the optical stimulation, providing direct evidence
that neuronal activity in the CeA can lead to increased visceral
nociception. A limitation of this study is the nature of the blad-
der distension protocol which requires the animals to be lightly
anesthetized in order to perform measures of the VMR. Future
studies to incorporate stimulation in awake, moving animals will
provide further insights into the role of specific brain regions in
the modulation of pain states.
Another important region involved in the modulation of pain
is the PFC. As with the amygdala, this region is particularly
associated with the affective component of the pain experience
(Tracey and Mantyh, 2007). In a recent investigation, the PFC
was injected with an adenoassociated virus (AAV), expressing
channelrhodopsin-2 under the control of the calcium/calmodulin
dependent kinase type II alpha (CaMKIIα) promoter (Ji and
Neugebauer, 2012). This allows selective expression within pyra-
midal neurons only, which are the major excitatory population in
the region, and avoids expression within inhibitory interneurons.
Two distinct regions of the PFC were explored, the infralimbic
(IL) and prelimbic (PL) areas. Following optogenetic stimulation
of the IL region, extracellular recordings were made from pyrami-
dal neurons in the IL and the nearby PL region with or without
peripheral stimulation, and also following noxious mechanical
stimulation of the knee joint. This approach helps provide a
better understanding of circuitry in the PFC. Excitation of neu-
rons in the IL region not only increases spontaneous activity
of other neurons in this area, but also the evoked responses
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to noxious and non-noxious stimulation. Optical stimulation
of the IL conversely led to a decrease in pyramidal neuron
excitability in the PL, suggesting an inverse relationship between
IL output and between PL activity (Ji and Neugebauer, 2012).
This study is a good example of the type of analysis that can
be achieved by combining optogenetic stimulation with electro-
physiological recordings. Future studies may be useful to inves-
tigate the effects of chronic pain states, as opposed to acute
noxious stimulation, on specific neuronal populations in the
brain.
Recently we have applied an optogenetic approach to explore
novel brain regions involved in opiate analgesia. Opioids are
important clinically, however their use is limited through the
development of tolerance and addiction (Ling et al., 2011).
Understanding the brain regions and cell types involved in
these processes are is important to help tackle the problem.
We had previously demonstrated that regulator of G protein
signaling 9-2 (Rgs9-2) is a negative modulator of morphine
tolerance (Zachariou et al., 2003). In our recent study we
demonstrated a potent role of Rgs9-2 in the nucleus accum-
bens (NAc, part of the brain reward center) in modulation of
morphine tolerance. Taking advantage of an optogenetic strat-
egy, we have showed that activation of Rgs9 expressing neurons
in the NAc leads to the rapid development of analgesic toler-
ance in the hot plate test (Gaspari et al., 2014). Using bacte-
rial artificial chromosome (BAC) lines expressing Cre recombi-
nase, we were also able to selectively stimulate the two main
NAc neuronal subpopulations: those expressing primarily D1
dopamine receptors (D1-type, direct pathway) and those enriched
in D2 dopamine receptors (D2-type, indirect pathway). Acti-
vation of channelrhodopsin-2 in each of these neuronal sub-
population demonstrated that morphine tolerance is modu-
lated by D1 type neurons, which is the population that mostly
expresses mu opioid receptors (MORs; Cui et al., 2014). In
accord with our earlier findings on a role of Rgs9-2 in the
NAc in morphine tolerance, activation of D1-type but not D2-
type neurons increases Rgs9-2 levels in the NAc (Gaspari et al.,
2014).
OPTOPHARMACOLOGY AND NOVEL OPTORECEPTORS IN PAIN
RESEARCH
Optogenetic approaches require the expression of an exogenous
light sensitive molecule in the target system. Although this has
proved a very useful tool in basic neurobiological research, by
definition this approach is of limited use clinically. An alternative
approach is the use of “optopharmacology”, that is administration
of compounds that confer light sensitivity onto a specific cell type
(Kramer et al., 2013). One recent example of this approach is the
discovery of a novel small molecule, optovin, which confers light
sensitivity on transient receptor potential cation channel, member
A1 (TRPA1; Kokel et al., 2013). This ion channel is part of the
transient receptor potential (TRP) family that act as transducers
of noxious stimuli at the periphery. TRPA1 is activated by noxious
cold and can also respond to chemical irritants such as formalin
and mustard oil, and may also play a role in mediating mechanical
nociception (Vay et al., 2012). The ability to optically stimulate
peripheral fibers expressing TRPA1 is therefore of experimental
interest to investigate the role of these neurons in animal and
human pain sensation. Optovin was identified by screening a
library of compounds in zebrafish embryos, which are normally
insensitive to light. This molecule was found to confer sensitivity
to violet light, and the effect was mediated by sensory neurons,
as a spinalized preparation retained the response. A subset of
mouse DRG cells also responded to optovin treatment, in a
light dependent manner. These were identified as TRPA1 express-
ing nociceptors. Using zebrafish homozygous for TRPA1 it was
demonstrated that this ion channel is required for the effects of
optovin. Expression of human TRPA1 in cell line derived from
human embryonic kidney (HEK) cells also conferred sensitivity
to optovin. The significance of this study lies in the ability to
modulate the pain sensing TRPA1 neurons, without the need for
genetic manipulations to confer this sensitivity. This approach
may be useful for research and treatment of pain in the future. In
particular, such an approach would allow selective optical control
of subpopulations of peripheral nociceptors without the need for
genetic manipulations.
Another approach has been the recent development of a
photoactive MOR, the main receptor mediating the analgesic
actions of morphine (Barish et al., 2013). This study designed a
recombinant receptor, containing the optically active component
of the rhodopsin molecule and the parts of the mu opioid receptor
responsible for MOR receptor protein and G protein signaling.
In a HEK cell system, this receptor is activated by light and has
the ability to activate endogenous MOR receptor intracellular
signaling pathways. Further development would be required, but
expression of this mutant MOR receptor could be a useful way
to overcome the side effects of MOR mediated analgesia, includ-
ing analgesic tolerance, which is associated with alterations in
MOR signal transduction pathways. Future work will determine
if selective activation of the MOR in the periphery by light
application prevents the CNS problems in patients requiring long
term morphine treatment.
FUTURE DIRECTIONS IN PAIN OPTOGENETICS
The power of optogenetics lies in the ability to achieve regional
and cell type specific neuronal activation. These methods provide
an unprecedented opportunity to probe the complexities of the
pain pathway at the peripheral, spinal and supraspinal levels.
Among the most exciting developments in the field to date is
the ability to produce pain-like behaviors in transgenic mice
by optical stimulation of nociceptors in the skin (Daou et al.,
2013). This allows direct investigation of nociceptor activation in
awake, freely moving animals, avoiding the stimulation of non-
nociceptive neurons and other cell types in the periphery. The
stimulus is also under precise temporal control, and avoids the
need for using other artificial stimuli such as chemical irritants.
Future studies to target specific subtypes of nociceptor will lead to
greater advances in our understanding of modality specificity, and
contribution of nociceptor subtypes to different forms of chronic
pain.
Somewhat surprisingly, to date no studies have taken advan-
tage of these tools within the dorsal horn however this may reflect
technical challenges in inserting optogenetic fibers into the spinal
cord. Considering the importance of this component of the pain
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pathway, however, it is likely that optogenetics will also provide
valuable new insights into this complex circuitry. Interneuron
based optogenetic experiments have been performed within the
ventral horn of the spinal cord, to investigate the contribution
of particular subsets to locomotor activity (Dougherty et al.,
2013). It is feasible that a similar approach could be employed in
the dorsal horn, given our increasing anatomical and molecular
knowledge of interneuron populations (Todd, 2010).
As described, a small number of studies have explored brain
areas in pain using optogenetics, however many other areas of the
pain matrix remain to be studied in this way. Both brain studies to
date have relied either on electrophysiological recordings (Ji and
Neugebauer, 2012) or behavioral outcomes in the anesthetized
animal (Crock et al., 2012). One of the most important directions
to be explored will be the combination of optogenetic brain
stimulation with behavior in the awake animal.
The studies described here are only the beginning of what
we expect to be fruitful and informative exploration of pain
circuits using optogenetic tools. It is likely that subsequent studies
will move beyond these initial proof of concept studies, and use
optogenetic tools to tackle unanswered questions regarding pain
circuitry.
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